Top

International Journal of Health Economics and Management

Open Access 29-03-2024 | Unstable Angina | Research article

Contribution of high-technology procedures to public healthcare expenditures: the case of ischemic heart disease in Portugal, 2002–2015

Authors: Wenkang Ma, Ana Timóteo, Vanessa Ribeiro, Céu Mateus, Julian Perelman

Published in: International Journal of Health Economics and Management

Abstract

The magnitude of the impact of technological innovations on healthcare expenditure is unclear. This paper estimated the impact of high-technology procedures on public healthcare expenditure for patients with ischemic heart disease (IHD) in Portugal. The Blinder–Oaxaca decomposition method was applied to Portuguese NHS administrative data for IHD discharges during two periods, 2008–2015 vs. 2002–2007 (N = 434,870). We modelled per episode healthcare expenditures on the introduction of new technologies, adjusting for GDP, patient age, and comorbidities. The per episode healthcare expenditure was significantly higher in 2008–2015 compared to 2002–2007 for IHD discharges. The increase in the use of high-technology procedures contributed to 28.6% of this growth among all IHD patients, and to 18.4%, 6.8%, 11.1%, and 29.2% for acute myocardial infarction, unstable angina, stable angina, and other IHDs, respectively. Changes in the use of stents and embolic protection and/or coronary brachytherapy devices were the largest contributors to expenditure growth. High-technology procedures were confirmed as a key driver of public healthcare expenditure growth in Portugal, contributing to more than a quarter of this growth.

Available only for authorised users

Abrantes-Metz, R. M. (2012). The contribution of innovation to health care costs: At least 50%?. http://ssrn.com/abstract=2121688 Accessed 31 December 2022

Achdut, L. (2019). Private expenditures on healthcare: Determinants, patterns and progressivity aspects. Israel Journal of Health Policy Research, 8(1), 87. https://doi.org/10.1186/s13584-019-0356-yCrossRefPubMedPubMedCentral

Administração Central do Sistema de Saúde (ACSS). (2012). Sistema de Classificação de Doentes. https://www.sns.gov.pt/entidades-de-saude/administracao-central-do-sistema-de-saude/. Accessed 31 December 2022

Amporfu, E., & Grépin, K. A. (2019). Measuring and explaining changing patterns of inequality in institutional deliveries between urban and rural women in Ghana: A decomposition analysis. International Journal for Equity in Health, 18(1), 123. https://doi.org/10.1186/s12939-019-1025-zCrossRefPubMedPubMedCentral

Austin, S. R., Wong, Y. N., Uzzo, R. G., Beck, J. R., & Egleston, B. L. (2015). Why summary comorbidity measures such as the Charlson comorbidity index and Elixhauser score work. Medical Care, 53(9), e65–e72. https://doi.org/10.1097/MLR.0b013e318297429cCrossRefPubMedPubMedCentral

Bannay, A., Chaignot, C., Blotière, P. O., Basson, M., Weill, A., Ricordeau, P., & Alla, F. (2016). The best use of the Charlson comorbidity index with electronic health care database to predict mortality. Medical Care, 54(2), 188–194. https://doi.org/10.1097/MLR.0000000000000471CrossRefPubMed

Barros, P. P. (2012). Health policy reform in tough times: The case of Portugal. Health Policy, 106(1), 17–22. https://doi.org/10.1016/j.healthpol.2012.04.008CrossRefPubMed

Bilgel, F., & Tran, K. C. (2013). The determinants of Canadian provincial health expenditures: Evidence from a dynamic panel. Applied Economics, 45(2), 201–212. https://doi.org/10.1080/00036846.2011.597726CrossRef

Blinder, A. S. (1973). Wage discrimination: Reduced form and structural estimates. The Journal of Human Resources, 8(4), 436–455. https://doi.org/10.2307/144855CrossRef

Bønaa, K. H., Mannsverk, J., Wiseth, R., Aaberge, L., Myreng, Y., Nygård, O., et al. (2016). Drug-eluting or bare-metal stents for coronary artery disease. New England Journal of Medicine, 375(13), 1242–1252. https://doi.org/10.1056/NEJMoa1607991CrossRefPubMed

Chandra, A., & Skinner, J. (2012). Technology growth and expenditure growth in health care. Journal of Economic Literature, 50(3), 645–680. https://doi.org/10.1257/jel.50.3.645CrossRef

Charlson, M. E., Pompei, P., Ales, K. L., & MacKenzie, C. R. (1987). A new method of classifying prognostic comorbidity in longitudinal studies: Development and validation. Journal of Chronic Diseases, 40(5), 373–383. https://doi.org/10.1016/0021-9681(87)90171-8

Charlson, M. E., Charlson, R. E., Peterson, J. C., Marinopoulos, S. S., Briggs, W. M., & Hollenberg, J. P. (2008). The Charlson comorbidity index is adapted to predict costs of chronic disease in primary care patients. Journal of Clinical Epidemiology, 61(12), 1234–1240. https://doi.org/10.1016/j.jclinepi.2008.01.006CrossRefPubMed

Charlson, M., Wells, M. T., Ullman, R., King, F., & Shmukler, C. (2014). The Charlson Comorbidity Index can be used prospectively to identify patients who will incur high future costs. PLoS ONE, 9(12), e112479. https://doi.org/10.1371/journal.pone.0112479

Chen,& Zhang, Y. P. Y. (2018). A decomposition method on employment and wage discrimination and its application in urban China (2002–2013). World Development, 110, 1–12. https://doi.org/10.1016/j.worlddev.2018.05.012CrossRef

Cohen, D. J. (2019). Are drug-eluting stents safer than bare-metal stents? NEJM Journal Watch. https://www.jwatch.org/na49095/2019/06/04/are-drug-eluting-stents-safer-bare-metal-stents. Accessed 31 December 2022

Cutler, D. M., & McClellan, M. (2001). Is technological change in medicine worth it? Health Affairs, 20(5), 11–29. https://doi.org/10.1377/hlthaff.20.5.11CrossRefPubMed

Dababneh, E., & Goldstein, S. (2022). Chronic ischemic heart disease selection of treatment modality. StatPearls. StatPearls Publishing. https://www.ncbi.nlm.nih.gov/books/NBK507703/. Accessed 31 December 2022.

Diário da República. (2018). Republic Diary No. 254/2018, Series 1 of 2018-09-07 [In Portuguese]. Diário da República /Health, 4497–4706. https://dre.pt/dre/en/detail/order/254-2018-116353279. Accessed 31 December 2022.

Dieleman, J. L., Squires, E., Bui, A. L., Campbell, M., Chapin, A., Hamavid, H., et al. (2017). Factors associated with increases in US health care spending, 1996–2013. JAMA, 318(17), 1668–1678. https://doi.org/10.1001/jama.2017.15927CrossRefPubMedPubMedCentral

Dybczak, K., & Przywara, B. (2010). The role of technology in health care expenditure in the EU. European Economy—Economic Papers 2008–2015. Directorate General Economic and Financial Affairs (DG ECFIN), European Commission. https://ideas.repec.org/p/euf/ecopap/0400.html. Accessed 31 December 2022.

Garrison, L. P., Neumann, P. J., Erickson, P., Marshall, D., & Daniel Mullins, C. (2007). Using real-world data for coverage and payment decisions: The ISPOR real-world data task force report why a real-world data task force? Growing use of evidence syntheses and outcomes research. Value in Health, 10(5), 326–335. https://doi.org/10.1111/j.1524-4733.2007.00186.xCrossRefPubMed

Gil, J., Abreu, L., Antunes, H., Gonçalves, M. L., Pires, M. I., dos Santos, L. F., et al. (2019). Application of risks scores in acute coronary syndromes. How does ProACS hold up against other risks scores? Arquivos Brasileiros De Cardiologia, 113, 20–30. https://doi.org/10.5935/abc.20190109CrossRefPubMedPubMedCentral

Green, M. A., & Rowe, F. (2021). Explaining the widening distribution of Body Mass Index: A decomposition analysis of trends for England, 2002–2004 and 2012–2014. Area, 53(2), 362–372. https://doi.org/10.1111/area.12675

Hartwig, J., & Sturm, J.-E. (2014). Robust determinants of health care expenditure growth. Applied Economics, 46(36), 4455–4474. https://doi.org/10.1080/00036846.2014.964829CrossRef

Hassan, M., Barragan, L., & Nan, C. (2019. Wage discrimination between U.S. born citizens vs. naturalized citizens or legal residents. Retrieved from https://www.researchgate.net/publication/341090127_Wage_Discrimination_Between_US_Born_Citizens_vs_Naturalized_Citizens_or_Legal_Residents

Institute for Health Metrics and Evaluation. (2019). Global Burden of Disease 2019 (GBD 2019) Data Resources. University of Washington. https://vizhub.healthdata.org/gbd-compare/. Accessed 31 December 2022.

Jann, B. (2008). The Blinder–Oaxaca decomposition for linear regression models. The Stata Journal, 8(4), 453–479. https://doi.org/10.1177/1536867X0800800401CrossRef

Kandaswamy, E., & Zuo, L. (2018). Recent advances in treatment of coronary artery disease: Role of science and technology. International Journal of Molecular Sciences, 19(2), 424–442. https://doi.org/10.3390/ijms19020424CrossRefPubMedPubMedCentral

Karbeah, J. M. (2020). Wage discrimination within health care professions: An intersectional analysis. Health Services Research, 55(S1), 70–71. https://doi.org/10.1111/1475-6773.13426

Liu, Y.-M. (2020). Population aging, technological innovation, and the growth of health expenditure: Evidence from patients with type 2 diabetes in taiwan. Value in Health Regional Issues, 21, 120–126. https://doi.org/10.1016/j.vhri.2019.07.012

Lobo, M. F., Azzone, V., Resnic, F. S., Melica, B., Teixeira-Pinto, A., Azevedo, L. F., et al. (2017). The Atlantic divide in coronary heart disease: Epidemiology and patient care in the US and Portugal. Revista Portuguesa de Cardiologia, 36(9), 583–593. https://doi.org/10.1016/j.repc.2016.09.021

Mayo Clinic. (2021). Angina treatment: Stents, drugs, lifestyle changes—What’s best? Mayo Clinic. https://www.mayoclinic.org/diseases-conditions/coronary-artery-disease/in-depth/angina-treatment/art-20046240. Accessed 1 January 2023

Mechanic, O. J., Gavin, M., & Grossman, S. A. (2022). Acute myocardial infarction. StatPearls. StatPearls Publishing. https://www.ncbi.nlm.nih.gov/books/NBK459269/. Accessed 31 December 2022

Meskarpour Amiri, M., Kazemian, M., Motaghed, Z., & Abdi, Z. (2021). Systematic review of factors determining health care expenditures. Health Policy and Technology, 10(2), 100498. https://doi.org/10.1016/j.hlpt.2021.01.004

Murthy, V. N. R., & Okunade, A. A. (2016). Determinants of U.S. health expenditure: Evidence from autoregressive distributed lag (ARDL) approach to cointegration. Economic Modelling, 59, 67–73. https://doi.org/10.1016/j.econmod.2016.07.001

Murthy, V. N. R., & Ketenci, N. (2017). Is technology still a major driver of health expenditure in the United States? Evidence from cointegration analysis with multiple structural breaks. International Journal of Health Economics and Management, 17(1), 29–50. https://doi.org/10.1007/s10754-016-9196-2CrossRefPubMed

National Institute for Health and Care Excellence. (2022). Stable angina | Treatment summaries. https://bnf.nice.org.uk/treatment-summaries/stable-angina/. Accessed 1 January 2023

Neumann, P. J., & Weinstein, M. C. (1991). The diffusion of new technology: Costs and benefits to health care. In A. C. Gelijins & E. A. Halm (Eds.), The Changing Economics of Medical Technology. National Academies Press (US). https://www.ncbi.nlm.nih.gov/books/NBK234309/. Accessed 31 December 2022

Nghiem, S. H., & Connelly, L. B. (2017). Convergence and determinants of health expenditures in OECD countries. Health Economics Review, 7(1), 29. https://doi.org/10.1186/s13561-017-0164-4CrossRefPubMedPubMedCentral

Nichols, M., Townsend, N., Scarborough, P., & Rayner, M. (2014). Cardiovascular disease in Europe 2014: Epidemiological update. European Heart Journal, 35(42), 2950–2959. https://doi.org/10.1093/eurheartj/ehu299CrossRefPubMed

Oaxaca, R. (1973). Male-female wage differentials in urban labor markets. International Economic Review, 14(3), 693–709. https://doi.org/10.2307/2525981CrossRef

Okunade, A. A., & Osmani, A. R. (2018). Technology, productivity, and costs in healthcare. In Oxford Research Encyclopedia of Economics and Finance (pp. 1–21). Oxford University Press. https://doi.org/10.1093/acrefore/9780190625979.013.64

Pereira, M., Azevedo, A., Lunet, N., Carreira, H., O’Flaherty, M., Capewell, S., & Bennett, K. (2013). Explaining the decline in coronary heart disease mortality in Portugal between 1995 and 2008. Circulation: Cardiovascular Quality and Outcomes, 6(6), 634–642. https://doi.org/10.1161/CIRCOUTCOMES.113.000264

Prieto, D. C., & Lago-Peñas, S. (2012). Decomposing the determinants of health care expenditure: The case of Spain. The European Journal of Health Economics, 13(1), 19–27. https://doi.org/10.1007/s10198-010-0276-9CrossRefPubMed

Rahimi, E., & Hashemi Nazari, S. S. (2021). A detailed explanation and graphical representation of the Blinder–Oaxaca decomposition method with its application in health inequalities. Emerging Themes in Epidemiology, 18(1), 12. https://doi.org/10.1186/s12982-021-00100-9CrossRefPubMedPubMedCentral

Rodriguez Santana, I., Aragón, M. J., Rice, N., & Mason, A. R. (2020). Trends in and drivers of healthcare expenditure in the English NHS: A retrospective analysis. Health Economics Review, 10(1), 20. https://doi.org/10.1186/s13561-020-00278-9CrossRefPubMedPubMedCentral

Roth, G. A., Mensah, G. A., Johnson, C. O., Addolorato, G., Ammirati, E., Baddour, L. M., et al. (2020). Global burden of cardiovascular diseases and risk factors, 1990–2019: Update from the GBD 2019 study. Journal of the American College of Cardiology, 76(25), 2982–3021. https://doi.org/10.1016/j.jacc.2020.11.010

Sharaf, M. F., & Rashad, A. S. (2016). Regional inequalities in child malnutrition in Egypt, Jordan, and Yemen: A Blinder–Oaxaca decomposition analysis. Health Economics Review, 6(1), 23. https://doi.org/10.1186/s13561-016-0097-3CrossRefPubMedPubMedCentral

Skinner, J., & Staiger, D. (2015). Technology diffusion and productivity growth in health care. The Review of Economics and Statistics, 97(5), 951–964. https://doi.org/10.1162/REST_a_00535CrossRefPubMedPubMedCentral

Statista. (2022). Portugal - Inflation rate 1986 - 2026. https://www.statista.com/statistics/372347/inflation-rate-in-portugal/. Accessed 31 December 2022

Timóteo, A. T., Gouveia, M., Soares, C., & Cruz Ferreira, R. (2020). Indirect costs of myocardial infarction in Portugal. Revista Portuguesa de Cardiologia, 39(5), 245–251. https://doi.org/10.1016/j.repc.2019.09.010

Urbano, J., & Bentes, M. (1990). Definição de produção do hospital: Os grupos de diagnósticos homogéneos. Saúde Pública, 8, 49–60.

Wilkins, E., Wilson, L., Wickramasinghe, K., Bhatnagar, P., Leal, J., Luengo-Fernandez, R., et al. (2017). European cardiovascular disease statistics 2017. https://ehnheart.org/images/CVD-statistics-report-August-2017.pdf. Accessed 31 December 2022

World Bank. (n.d.). GDP per capita (constant 2010 US$)—Portugal. https://data.worldbank.org/indicator/NY.GDP.PCAP.KD?end=2020&locations=PT&start=1960&view=chart. Accessed 31 December 2022

World Health Organization/Europe. (2021). Cardiovascular diseases—data and statistics. https://www.euro.who.int/en/health-topics/noncommunicable-diseases/cardiovascular-diseases/data-and-statistics. Accessed 31 December 2022

Wu, P.-C., Liu, S.-Y., & Pan, S.-C. (2014). Nonlinear relationship between health care expenditure and its determinants: A panel smooth transition regression model. Empirica, 41(4), 713–729. https://doi.org/10.1007/s10663-013-9233-zCrossRef

You, X., & Okunade, A. A. (2017). Income and technology as drivers of Australian Healthcare Expenditures. Health Economics, 26(7), 853–862. https://doi.org/10.1002/hec.3403

Title: Contribution of high-technology procedures to public healthcare expenditures: the case of ischemic heart disease in Portugal, 2002–2015
Authors: Wenkang Ma
Ana Timóteo
Vanessa Ribeiro
Céu Mateus
Julian Perelman
Publication date: 29-03-2024
Publisher: Springer US
Keywords: Unstable Angina
Brachytherapy
Published in: International Journal of Health Economics and Management
Print ISSN: 2199-9023
Electronic ISSN: 2199-9031
DOI: https://doi.org/10.1007/s10754-024-09372-5

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Contribution of high-technology procedures to public healthcare expenditures: the case of ischemic heart disease in Portugal, 2002–2015

Abstract

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Please log in to get access to this content